Nuvasive reported $823.31M in Current Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Abiomed ABMD:US $ 1060.36M 83.89M
Atricure ATRC:US $ 206.17M 6.56M
Baxter International BAX:US $ 7882M 291M
Becton, Dickinson and BDX:US $ 9547M 605M
Cardiovascular Systems CSII:US $ 241.85M 3.47M
Cooper Companies COO:US $ 1597.7M 140.5M
Dexcom DXCM:US $ 3808.7M 62.1M
Edwards Lifesciences EW:US $ 3263.1M 21.8M
Globus Medical GMED:US $ 891.17M 25.43M
Haemonetics HAE:US $ 687.78M 68.25M
Hologic HOLX:US $ 3909M 27.6M
Inogen INGN:US $ 315.45M 2.68M
Insulet PODD:US $ 1309.1M 23.7M
Integra Lifesciences IART:US $ 1.14B 71.36M
Intuitive Surgical ISRG:US $ 9737.9M 3934.7M
Medtronic MDT:US $ 22135M 924M
Merit Medical Systems MMSI:US $ 492.63M 14.54M
Nuvasive NUVA:US $ 823.31M 31.1M
Orthofix International OFIX:US $ 255.19M 0.09M
Stryker SYK:US $ 8825M 100M
Tandem Diabetes Care TNDM:US $ 835.04M 16.58M
Teleflex TFX:US $ 1385.34M 108.86M
Zimmer Biomet Holdings Inc ZBH:US $ 4.46B 53.9M